Co-Diagnostics Inc (CODX) Stock Price, Quote & News

Company Profile

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, hum...

Industry: Medical Devices

Sector: Healthcare

Phone: 801 438 1036

Website: co-dx.com

Address:

2401 S. Foothill Drive, Suite D, Salt Lake City, United States

spotthedog Jul. 4 at 11:20 AM

$CODX Do you see this as a negative for Co-Diagnostics, or possible optimism that WHO are beginning to select partners? How do you holders assess the CODX stock if they are not successful in their application to be an approved Ebola tester? https://www.who.int/news/item/02-07-2026-who-adds-first-diagnostic-test-for-ebola-bundibugyo-virus-to-its-emergency-use-listing

1 · Reply

PharmGal Jul. 4 at 12:59 AM

$CODX Shanghai Biotech seems to be the maker of the first listed PCR test for the WHO. 19 employees in China, otherwise Know nothing about them. @Chessdoc https://extranet.who.int/prequal/sites/default/files/document_files/EUL%20BDBV_List%20of%20BDBV%20IVDs.pdf

1 · Reply

Chessdoc Jul. 4 at 12:46 AM

$CODX Am I missing something, or was no specific test maker disclosed? https://www.who.int/news/item/02-07-2026-who-adds-first-diagnostic-test-for-ebola-bundibugyo-virus-to-its-emergency-use-listing

0 · Reply

HMIC Jul. 3 at 12:35 PM

$CODX Look for a run July 6-10. 7.55

1 · Reply

Minutiae Jul. 3 at 6:30 AM

$CODX Jul 2 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx

0 · Reply

Minutiae Jul. 3 at 6:27 AM

$CODX Jul 2 CODX volume 1,004,637 closing at $2.99. 35,510 after-hour shares trading at $2.92 to $3.05. FINRA Short Sale Volume 388,336 shorted shares out of 562,191. CODX short volume 69%. https://www.nasdaq.com/market-activity/stocks/codx/advanced-charting

0 · Reply

SmallPhish Jul. 3 at 3:50 AM

$CODX When was the last profitable quarter? 2023?

1 · Reply

DoucheJdwilken65 Jul. 2 at 11:23 PM

$CODX

0 · Reply

Universelaw Jul. 2 at 10:22 PM

$CODX

0 · Reply

Apustaja Jul. 2 at 7:32 PM

$CODX is there something here or only last pumps baggies hoping to something to happen?

0 · Reply

Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test

Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States

Jun 25, 2026, 9:00 AM EDT - 9 days ago

Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City

Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast

Apr 30, 2026, 9:00 AM EDT - 2 months ago

Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

Co-Diagnostics to expand commercial, distribution territory across South Asia

2026-03-20T12:11:57.000Z - 3 months ago

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health

Nov 18, 2025, 9:00 AM EST - 8 months ago

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

Co-Diagnostics Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 8 months ago

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

Oct 29, 2025, 12:51 PM EDT - 8 months ago

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 28, 2025, 9:33 AM EDT - 8 months ago

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia

Oct 22, 2025, 8:30 AM EDT - 9 months ago

Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Sep 17, 2025, 9:47 AM EDT - 10 months ago

Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains

Sep 11, 2025, 9:30 AM EDT - 10 months ago

PharmGal Jul. 4 at 12:59 AM

1 · Reply

Chessdoc Jul. 4 at 12:46 AM

$CODX Am I missing something, or was no specific test maker disclosed? https://www.who.int/news/item/02-07-2026-who-adds-first-diagnostic-test-for-ebola-bundibugyo-virus-to-its-emergency-use-listing

0 · Reply

HMIC Jul. 3 at 12:35 PM

$CODX Look for a run July 6-10. 7.55

1 · Reply

Minutiae Jul. 3 at 6:30 AM

$CODX Jul 2 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx

0 · Reply

Minutiae Jul. 3 at 6:27 AM

0 · Reply

SmallPhish Jul. 3 at 3:50 AM

$CODX When was the last profitable quarter? 2023?

1 · Reply